FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Op-Ed: Stalin Believed in Predestination – Just Not the Calvinist Kind

Obama makes the case for el Sayed and a Democratic Party that can disagree

Constitutional Attorney: If We’re Not Careful, the US Could End Up Like France

Ukraine’s Starlink restored as Elon Musk claims Kyiv violated terms of service ‘to kill people’

Breaking: ‘Explosion’ at Quaker Oats Factory Rocks Midwest City as Large Smoke Cloud Looms

Obama compares Trump’s White House renovations to ‘Saddam Hussein opening a Cheesecake Factory’ at Ohio rally

Trump’s go-to Michigan auto worker gets a job and the spotlight

Felon Accused of Shooting National Guardsman Slapped With Federal Charges

This Isn’t Want Dems Had in Mind: Cali’s Wealth Tax Plan Handed Billionaire Zuckerberg a Massive Pay Increase

Did He Forget About 9/11? Muslim Brotherhood-Connected El-Sayed Said US Was ‘A Lot More Safe’ Under INS

Second Amendment fight moves beyond guns with Supreme Court poised for big ruling

Bush dynasty delivers another blow to GOP in Texas Senate battle as family member breaks ranks

Breaking: US Evacuates Middle East in ‘Sudden Exodus’ as ‘Advanced Stages’ of Iranian Assassination Plots Come to Light

Obama prepares to rally with Michigan Dem who once delivered scathing verdict on his presidency

Omar’s deleted tweet could give clue on alleged brother marriage

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”